Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Osteoporosis|June 14, 2016
Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab TherapyJosé L Hernández, Raquel López-Mejías, Ricardo Blanco, et al.
Rheumatology International|July 6, 2015
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patientsFernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, et al.
Mediators of Inflammation|July 1, 2014
Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effectFernanda Genre, Raquel López-Mejías, Javier Rueda-Gotor, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature reviewJavier Loricera, Ricardo Blanco, José L Hernández, et al.
Clinical and Experimental Rheumatology|July 10, 2014
Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature reviewVanesa Calvo-Río, David de la Hera, Emma Beltrán-Catalán, et al.
Clinical and Experimental Rheumatology|February 18, 2014
Revisiting clinical differences between hypersensitivity vasculitis and Henoch-Schönlein purpura in adults from a defined populationVanesa Calvo-Río, Javier Loricera, Francisco Ortiz-Sanjuán, et al.
Scientific Reports|September 7, 2017
Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritisSara Remuzgo-Martínez, Fernanda Genre, Santos Castañeda, et al.
Clinical and Experimental Rheumatology|April 8, 2016
The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label studyMontserrat Santos-Gómez, Vanesa Calvo-Río, Ricardo Blanco, et al.
The Journal of Dermatological Treatment|May 11, 2017
Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasisFernanda Genre, Susana Armesto, Alfonso Corrales, et al.
Arthritis Research & Therapy|July 12, 2014
Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritisMercedes García-Bermúdez, Raquel López-Mejías, Fernanda Genre, et al.
Pageof 6